Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Norio Ohmagari"'
Publikováno v:
Expert Review of Anti-infective Therapy. 20:1603-1614
Antimicrobial resistance (AMR) is a major threat to global health requiring continuous development of new antimicrobial agents. Antimicrobial research and development (RD) should be promoted in the pharmaceutical industry and academia to ensure susta
Autor:
Ataru Moriya, Ayano Motohashi, Hitoshi Oki, Norio Ohmagari, Kazuhisa Mezaki, Erina Isaka, Satoshi Ide, Keiji Nakamura, Honami Ando, Ayaka Usami, Masami Kurokawa, Hidetoshi Nomoto, Takahito Nakamoto, Kei Yamamoto
Publikováno v:
Japanese Journal of Infectious Diseases. 75:309-313
Several commercial nucleic acid amplification tests (NAAT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. We used six kits available in Japan in 13 NAAT-positive specimens with crossing point values >36 and 7 NA
Autor:
Sho Nakakubo, Yoko Unoki, Koji Kitajima, Mari Terada, Hiroyuki Gatanaga, Norio Ohmagari, Isao Yokota, Satoshi Konno
Publikováno v:
Viruses
Volume 15
Issue 3
Pages: 671
Volume 15
Issue 3
Pages: 671
Clinical features of COVID-19 are diverse, and a useful tool for predicting clinical outcomes based on clinical characteristics of COVID-19 is needed. This study examined the laboratory values and trends that influence mortality in hospitalised COVID
Autor:
Natsumi Inamura, Shohei Yamamoto, Maki Konishi, Akihito Tanaka, Mitsuru Ozeki, Norio Ohmagari, Yusuke Oshiro, Tetsuya Mizoue
Publikováno v:
GHM Open. 2:51-53
Autor:
Norio Ohmagari
Publikováno v:
Nihon Naika Gakkai Zasshi. 109:1932-1937
Autor:
Mitsuru Ozeki, Kenji Maeda, Wataru Sugiura, Shohei Yamamoto, Akihito Tanaka, Kumi Horii, Kaori Okudera, Norio Ohmagari, Maki Konishi, Tetsuya Mizoue, Junko S Takeuchi, Hiroaki Mitsuya, Kouki Matsuda, Haruhito Sugiyama, nobuyoshi Aoyanagi
BackgroundWhile increasing coverage of effective vaccines against coronavirus disease 2019 (COVID-19), emergent variants raise concerns about breakthrough infections. Data are limited, however, whether breakthrough infection during the epidemic of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d64c4852b091611f20bbb0151aeaa7e
https://doi.org/10.1101/2021.10.20.21265301
https://doi.org/10.1101/2021.10.20.21265301
Autor:
Hiroaki Mitsuya, Tadashi Maemura, Ichiro Nakachi, Rie Baba, Riccardo Valdez, Hiroyuki Nagai, Hideaki Nakajima, Tetsuya Suzuki, Michiko Koga, Junichi Ochi, Tadaki Suzuki, Aubree Gordon, Samantha Loeber, Kensuke Fujita, Kenji Maeda, Maki Kiso, Carmen Gherasim, David A. Baker, Norio Sugaya, Makoto Saito, Noriko Nakajima, Yoshihiro Kawaoka, Takayuki Ogura, John J. Baczenas, Moe Okuda, Hideaki Kato, Kiyoko Iwatsuki-Horimoto, Shuetsu Fukushi, Hiroshi Ueki, Tiago J. S. Lopes, Yudai Kuroda, Shiho Chiba, Tokiko Watanabe, Makoto Kuroda, Norio Ohmagari, Tsuguto Fujimoto, Masaki Imai, Osamu Akasaka, Peter Halfmann, Masato Hatta, Michiko Ujie, Eisuke Adachi, Ken Maeda, Shelby L. O’Connor, Hiroshi Yotsuyanagi, Atsuhiro Yasuhara, Shinya Yamamoto, Amie J. Eisfeld, Yusuke Miyazato, Kenta Takahashi, Keiko Mitamura, Yuko Sakai-Tagawa, Mutsumi Ito, Shin ichiro Hattori, Morio Nakamura, Yuri Furusawa, David H. O’Connor, Seiya Yamayoshi, Kazuma Yagi
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are of concern, with the P.1 variants dominating in Brazil. Brazil is now seeing a record number of deaths. Here, we report that the pathogenicity in hamsters of a P.1
Autor:
Wataru Sugiura, Hiroshi Ohtsu, Sho Saito, Mari Terada, Yusuke Asai, Shinya Tsuzuki, Norio Ohmagari, Nobuaki Matsunaga, Kayoko Hayakawa, Satoshi Kutsuna
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
BMJ Open
BMJ open
BMJ Open
BMJ open
ObjectivesTo investigate the risk factors contributing to severity on admission. Additionally, risk factors of worst severity and fatality were studied. Moreover, factors were compared based on three points: early severity, worst severity and fatalit
Autor:
Kei Yamamoto, Jin Takasaki, Norio Ohmagari, Katsuji Teruya, Maki Nagashima, Kenji Sadamasu, Isao Yoshida, Masami Kurokawa, Mami Nagashima, Noriko Kinoshita, Kenji Maeda
Publikováno v:
Journal of Infection and Chemotherapy
Rapid antigen tests (RATs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have advantages over viral culture in terms of cost and rapidity of testing, but they have low sensitivity. In addition, RATs tend to be negative from approxi
Autor:
Mikako, Ueno, Naoko, Iwata-Yoshikawa, Akihiro, Matsunaga, Tadashi, Okamura, Sho, Saito, Shinobu, Ashida, Isao, Yoshida, Mami, Nagashima, Hiroyuki, Asakura, Yuu, Yaoita, Jun, Suzuki, Kenji, Sadamasu, Kazuhisa, Yoshimura, Satoshi, Kutsuna, Nozomi, Shiwa-Sudo, Noriyo, Nagata, Tadaki, Suzuki, Akinori, Suzuki, Miwa, Okamoto, Moto, Kimura, Norio, Ohmagari, Ryu, Miura, Yukihito, Ishizaka
Publikováno v:
Antiviral Research. 201:105297
Monoclonal antibody therapy is a promising option for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a cocktail of antibodies (REGN-COV) has been administered to infected patients with a favorable outcome. However, it is